Grant: Discovery Grants Program - Individual
University of Waterloo
$26,000.00
Semiconductor sensor arrays for electrophysiology and cellular analysis
FY 2012-13
Summary
The proposed program seeks to develop semiconductor chips that interface with biological cells to increase the rate at which new drug compounds are screened. New platforms will enable more rapid screening of target compounds in ion channel and G-protein coupled receptor (GPCR) drug discovery compared to commercially-available technologies. The planned effort will leverage established complementary metal-oxide-semiconductor (CMOS) manufacturing to fabricate low-cost, disposable silicon integrated-circuit sensors that interface with biological cells directly on chip. CMOS is the technology of choice for high-throughput cellular analysis because it enables denser integration of sensors compared to passive well plates used in conventional drug screening. This technology also permits parallel cellular recording through integration of data-acquisition and processing circuits at each on-chip sensing location. In addition, CMOS allows transducers and sensor electronics to exist together in very close proximity, permitting a high-bandwidth, low-interference interface for accurately recording cell currents. Furthermore, CMOS technology, which is used in the design of virtually all commodity microelectronics, is very low cost because it leverages the tremendous economies of scale associated with the semiconductor manufacturing industry. One objective is to design CMOS sensor arrays for high-throughput drug-screening based on planar patch-clamp electrophysiology. Another objective is to develop CMOS sensor arrays for cellular impedance analysis to observe cytotoxicity, receptor-ligand interactions, and cellular adhesion and spreading. These new screening technologies will benefit the Canadian pharmaceutical industry by enabling more thorough analysis of potential drug toxicity in less time, allowing new drugs to be brought to market more quickly and at a lower cost. The proposed program will also train highly qualified personnel in CMOS microsystem development who will contribute to the growth of Canada's biotechnology and semiconductor research and industrial sectors.
Program
Discovery Grants Program - Individual
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
418287-2012
Name nom
Levine, Peter
Department département
Electrical & Computer Engineering
Organization id
33
Institution établissement
University of Waterloo
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2012
Award amount
26000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1510
Committee name en
Electrical and Computer Engineering
Committee name fr
Génie électrique et informatique
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
2504
Research subject group en
Electrical and electronic engineering
Research subject group fr
Génie électrique et électronique
Research subject en
Integrated circuits
Research subject fr
Circuits intégrés
Partie
1
Nb partie
5
Application title
Semiconductor sensor arrays for electrophysiology and cellular analysis
Keyword
NSERC
Application summary
The proposed program seeks to develop semiconductor chips that interface with biological cells to increase the rate at which new drug compounds are screened. New platforms will enable more rapid screening of target compounds in ion channel and G-protein coupled receptor (GPCR) drug discovery compared to commercially-available technologies. The planned effort will leverage established complementary metal-oxide-semiconductor (CMOS) manufacturing to fabricate low-cost, disposable silicon integrated-circuit sensors that interface with biological cells directly on chip. CMOS is the technology of choice for high-throughput cellular analysis because it enables denser integration of sensors compared to passive well plates used in conventional drug screening. This technology also permits parallel cellular recording through integration of data-acquisition and processing circuits at each on-chip sensing location. In addition, CMOS allows transducers and sensor electronics to exist together in very close proximity, permitting a high-bandwidth, low-interference interface for accurately recording cell currents. Furthermore, CMOS technology, which is used in the design of virtually all commodity microelectronics, is very low cost because it leverages the tremendous economies of scale associated with the semiconductor manufacturing industry. One objective is to design CMOS sensor arrays for high-throughput drug-screening based on planar patch-clamp electrophysiology. Another objective is to develop CMOS sensor arrays for cellular impedance analysis to observe cytotoxicity, receptor-ligand interactions, and cellular adhesion and spreading. These new screening technologies will benefit the Canadian pharmaceutical industry by enabling more thorough analysis of potential drug toxicity in less time, allowing new drugs to be brought to market more quickly and at a lower cost. The proposed program will also train highly qualified personnel in CMOS microsystem development who will contribute to the growth of Canada's biotechnology and semiconductor research and industrial sectors.